Véronique Lecault
Founder chez ABCELLERA BIOLOGICS INC.
Fortune : 48 M $ au 29/02/2024
Profil
Le Dr Vronique Lecault est vice-présidente de Lineage Biosciences, Inc. et directrice de l'exploitation et directrice d'AbCellera Biologics, Inc. Elle est membre du conseil d'administration de Channel Biologics Pty Ltd. et d'AbCellera Biologics, Inc. Elle a obtenu un diplôme de premier cycle à l'Université d'Ottawa et un doctorat à l'Université de la Colombie-Britannique.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
14/01/2024 | 9 530 340 ( 3,26% ) | 48 M $ | 29/02/2024 |
Postes actifs de Véronique Lecault
Sociétés | Poste | Début |
---|---|---|
ABCELLERA BIOLOGICS INC. | Founder | 08/11/2012 |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2018 |
AbCellera Australia Pty Ltd. | Director/Board Member | 01/09/2019 |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 01/11/2020 |
Formation de Véronique Lecault
University of British Columbia | Doctorate Degree |
University of Ottawa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
AbCellera Biologics, Inc. | |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
AbCellera Australia Pty Ltd. |